Publications

Journal Article Ppublish 1 citation

PubMed: 40524461 DOI: 10.1111/bjh.20136

Can we identify individuals at risk to develop multiple myeloma? A machine learning-based predictive model.

Br J Haematol 207(2):387-394

Authors: Moshe Mittelman, Ariel Israel, Howard S Oster, Michael Leshchinsky, Yatir Ben-Shlomo, Eldad Kepten, Osnat Jarchowsky Dolberg, Ran Balicer, Galit Shaham

Affiliations

  • Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Leumit Health Services, Tel Aviv, Israel.
  • Department of Internal Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Innovation Division, Clalit Health Services, Clalit Research Institute, Tel Aviv-Yafo, Israel.
  • Department of Hematology, Meir Medical Center, Kfar Saba, Israel.

Abstract

Multiple myeloma evolves unnoticed over years, and when diagnosed, organ damage is common. Electronic health records (EHR) can help in developing predictive models identifying 'healthy' people at risk. MM patients from Clalit Health Services (2002-2019) were matched with healthy controls. Stage I: EHR from 5 years prior to MM diagnosis were reviewed and >200 parameters were compared (patients vs. controls). Stage II: Establishing xgboost model predicting 5 year risk for MM, with validation. Stage III: A simplified logistic regression model for community, requiring 20 variables (Age; Hb; RBC; MCV; RDW; WBC; neutrophils; lymphocytes; monocytes; basophils; glucose; creatinine; total protein; albumin; calcium; uric acid; bilirubin; HDL-C; LDL-C; triglycerides). EHR from the pre-MM period of 4256 patients were compared to controls. Future MM patients had higher ESR, lower Hb, ANC, neutrophil/lymphocyte ratio, higher globulins and ferritin, more immune deficiencies, MDS and FMF. They took fewer tranquilizers, anti-diabetics and statins. Using labs from future MM (n = 19 129) and controls (n = 382 580, 20:1), a predictive model was developed (ROC AUC = 0.836). The simple LR model provided individual risk prediction for MM within 5 years (AUC = 0.72). Two models with machine learning predict the risk of myeloma in 'healthy' individuals within 5 years. The models can be used in practice.

MeSH

Lymphocytes, Neutrophils, Machine Learning, Multiple Myeloma, Learning

Cited by